Risking health to avoid in injections - Preferences of Canadians with type 2 diabetes
Improved glycemic control reduces the risk of long-term diabetes complications (1–3). However, subcutaneous insulin injections represent a barrier to achieving “optimal” blood glucose levels, particularly among type 2 diabetic patients (4). Indeed, some patients even delay initiation of therapy to avoid injections (5). This study used conjoint analysis to quantify the relative importance that Canadian patients with type 2 diabetes place on short-term treatment outcomes and on the frequency of insulin injections.
Hauber, A. B., Johnson, F. R., Sauriol, L., & Lescrauwaet, B. (2005). Risking health to avoid in injections - Preferences of Canadians with type 2 diabetes. Diabetes Care, 28(9), 2243-2245. DOI: 10.2337/diacare.28.9.2243